Podcasts about vaccine trials

- Chemtrails and Microscopic Life Forms (0:00) - US Army's Role in Flu Seasons (4:18) - Historical Medical Experiments by the US Government (43:50) - MK Ultra and Human Radiation Experiments (51:29) - Operation White Coat and the Manhattan Project (59:34) - COVID-19 Vaccine Trials and Depopulation Agenda (1:07:18) - Pentagon's Bio Defense Experiments and COVID-19 Origins (1:14:26) - Defending Against Bio Warfare (1:19:10) - Promoting Health and Wellness Resources (1:20:53) - Emergency Cures and Knowledge Sharing (1:25:43) - Critique of Government and Health Authorities (1:26:45) - Book Review: The Secret History of the War on Cancer (1:31:04) - Environmental Factors and Cancer (1:36:36) - Eugenics and Cancer (1:37:40) - Sponsorship and Preparedness (1:40:00) - Microscopy Investigation with Dr. Jane Ruby (1:46:29) - Observations and Findings (1:50:33) - Conclusion and Future Plans (2:01:17) For more updates, visit: http://www.brighteon.com/channel/hrreport NaturalNews videos would not be possible without you, as always we remain passionately dedicated to our mission of educating people all over the world on the subject of natural healing remedies and personal liberty (food freedom, medical freedom, the freedom of speech, etc.). Together, we're helping create a better world, with more honest food labeling, reduced chemical contamination, the avoidance of toxic heavy metals and vastly increased scientific transparency. ▶️ Every dollar you spend at the Health Ranger Store goes toward helping us achieve important science and content goals for humanity: https://www.healthrangerstore.com/ ▶️ Sign Up For Our Newsletter: https://www.naturalnews.com/Readerregistration.html ▶️ Brighteon: https://www.brighteon.com/channels/hrreport ▶️ Join Our Social Network: https://brighteon.social/@HealthRanger ▶️ Check In Stock Products at: https://PrepWithMike.com

Dr. Paul Alexander Liberty Hour – Kennedy Jr. suspended the Biden administration's multimillion-dollar contract to create a new COVID-19 vaccine...IMO, major methodological flaws with the Vaxart study that warrants it be terminated! The Vaxart vaccine was funded explicitly through an agreement with the Biomedical Advanced Research and Development Authority (BARDA), which is a...

“When I got my COVID vaccine, my reaction started within an hour, and it started with tingling down the same arm as my injection. It moved to my other arm, then it moved to my legs, and then it moved to my head, into my brain, and I had this horrific electrical, pulsating sensation through my body 24/7.”Brianne Dressen was left severely injured after participating in the AstraZeneca COVID-19 vaccine trials. She's the co-founder of the nonprofit React19, which helps people impacted by COVID-19 vaccine injuries. React19 now advocates on behalf of over 36,000 people.“We can't be found in any kind of database that the public or anyone beyond the government can access,” she says. “All of the programs that we've developed, they work together in concert to build an avenue for healing for the people that literally have no avenue.”She's the subject of the new book “Worth a Shot?: Secrets of the Clinical Trial Participant Who Inspired a Global Movement.”Views expressed in this video are opinions of the host and the guest, and do not necessarily reflect the views of The Epoch Times.

Buckle up—this episode is coming in hot! As Pfizer continues its slow release of Covid-19 mRNA vaccine study data, we dig into what's been uncovered so far.Today's guest, Sasha Latypova, a former pharmaceutical industry executive with over 20 years in clinical research and regulatory affairs, shares her findings from the first 400 pages released through a FOIA request. Her analysis raises serious concerns, including whether Pfizer ever conducted proper safety testing and the CDC/FDA's claims that the vaccine “stays in the injection site.” Spoiler: The data suggests otherwise. We're linking the full Pfizer documents on our website so you can see the data for yourself!

Episode #1163 Vaccine Trials & Betrayal: The Brianne Dressen Story When Utah mom and preschool teacher Brianne Dressen volunteered for AstraZeneca's COVID-19 vaccine trial, she believed she was doing her part to help end the pandemic. Instead, her life was shattered by severe neurological injuries. But the real horror began when the medical establishment turned its back on her. Despite a diagnosis of “post-vaccine neuropathy” from the NIH, AstraZeneca offered her a mere $1,200 for a lifetime of suffering. Worse, she discovered a system designed to suppress stories like hers—where Big Pharma, government agencies, and mainstream media collude to silence the vaccine-injured. Now, Dressen is fighting back, exposing the web of deceit that controls public health. What does her story reveal about the dark side of medical trials, corporate corruption, and the silencing of dissent? GUEST: Brianne Dressen is a Utah mother, former preschool teacher, and AstraZeneca vaccine trial participant who developed severe neurological injuries. Now a leading advocate for vaccine injury awareness, she co-founded React19 to support those harmed by COVID-19 vaccines. WEBSITE: https://www.react19.org BOOK: Worth a Shot?: Secrets of the Clinical Trial Participant Who Inspired a Global Movement―Brianne Dressen's Story SUPPORT OUR SPONSORS!!! HIMS - Making Healthy and Happy Easy to Achieve Sexual Health, Hair Loss, Mental Health, Weight Management START YOUR FREE ONLINE VISIT TODAY - HIMS dot com slash STRANGE https://www.HIMS.com/strange SHIP STICKS Skip airport stress and costly airline fees with complimentary insurance, real-time tracking, dedicated support, and on-time delivery. ShipSticks is offering our listeners 20% off your first shipment when you go to Shipskicks.com and use the code STRANGE. Go to https://www.shipsticks.com and use the code STRANGE to get 20% off your first shipment and save yourself the hassle this ski season. That's S-H-I-P-S-T-I-C-K-S.com. Make sure you use the code STRANGE so they know we sent you. UP FIRST PODCAST FROM NPR Up First frees you from the all-day scroll obsession by telling you everything you need to know, in an easy 15 minutes. NO BS. Just the facts. Up First is the cure you need for your news fatigue. Listen now to the Up First podcast from NPR. BECOME A PREMIUM SUBSCRIBER!!! https://strangeplanet.supportingcast.fm Three monthly subscriptions to choose from. Commercial Free Listening, Bonus Episodes and a Subscription to my monthly newsletter, InnerSanctum. We and our partners use cookies to personalize your experience, to show you ads based on your interests, and for measurement and analytics purposes. By using our website and services, you agree to our use of cookies as described in our Cookie Policy. Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://strangeplanet.supportingcast.fm/

Dr. David Curiel, a professor of radiation oncology at Wash U, discusses clinical trials for a new nasal Covid-19 vaccine with KMOX Health Editor Fred Bodimer.

Order today at http://www.1775coffee.com/BRAND - code BRAND  to save 15% off your order Visit http://www.Pawsitive.com, grab a kit, and use code BRAND to save 15%   Today I'm talking to Aaron Siri, the attorney taking on Big Pharma and exposing the cracks in vaccine mandates and public health regulation. From forcing the CDC to release hidden data to challenging mandates all the way to the Supreme Court, Aaron's work uncovers how profit-driven motives and regulatory conflicts of interest shape the public health narrative. We discuss the shocking lack of rigorous safety trials for vaccines, the immunity granted to pharmaceutical companies, and the contentious claims about vaccines and autism. Aaron pulls back the curtain on the systems that prioritize profits over transparency, raising urgent questions about science, power, and individual rights.

Darshan's LinkedIn: https://www.linkedin.com/in/darshankulkarni/My PatientACE recruitment company: https://patientace.com/CRIO: http://www.clinicalresearch.ioInato: https://go.inato.com/3VnSro6Join me at my conference! http://www.saveoursites.comText Me: (949) 415-6256My podcast is Random Musings From The Clinical Trials GuruListen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7aGET THE BOOK! https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1?keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorrText "guru" to 855-942-5288 to join VIP list!My blog: http://www.TheClinicalTrialsGuru.comMy CRO and Site Network: http://www.DSCScro.comMy CRA Academy: http://www.TheCRAacademy.comMy CRC Academy: http://www.TheCRCacademy.comLatinos In Clinical Research: http://www.LatinosinClinicalResearch.comThe University Of Clinical Research: https://www.theuniversityofclinicalresearch.com/My TikTok: DanSfera

A closer look at unexpected trends in dating as more young people are ditching the dating apps to find love in person. Also, inside the push to create a safe and effective vaccine for breast cancer. Plus, in honor of Hispanic Heritage Month, pastry chef Paola Velez shares a delicious coquito cheesecake recipe.

Trials of a cancer 'vaccine' have begun and presenter James meets Steve, one of the first patients to trial the new treatment, Steve remembers his shock at being diagnosed with colorectal cancer in his 40s and tells the story of how he became involved in this pioneering research into tackling cancer.The vaccine is based on the same mRNA technology as the Pfizer-BioNTech COVID-19 vaccine and James heads to the University of Cambridge to find out how the early work into cancer vaccines became the foundation for the rapid rollout of the covid vaccine. In the lab, molecular biologist Dr Anne Willis and immunologist Dr James Thaventhiran explain how the vaccine is personalised to target the unique make-up of an individual patients' cancer cells, and how if the trials are successful they could open the door to mRNA treatments being used to treat a wide range of diseases.Also, Imperial College London cyber security researcher Dr Saira Ghafur joins James in the studio to explain why healthcare is a growing target for cyber attackers and how we can prepare for the next one because, as Saira says, it really is a case of "when" not "if".Presented by James Gallagher Produced by Tom Bonnett with Hannah Robins Assistant Producer: Katie Tomsett Editor: Holly Squire

Dr. Natalie Gentile, physician and founder of Direct Care physicians of Pittsburgh, calls in to talk with Larry about the great potential the breast cancer vaccine has.

Today on Moving medicine forward we have a great discussion with Adam Roth, Vice President, Research Site Services at CTI. In this conversation we take a deep dive into how our Clinical Research Center in Cincinnati OH supports clinical research. We focus on the work the site has done on Vaccine trials including how the site supported the Covid-19 Vaccine trials during the pandemic.

The Pride in our Health Podcast is BACK! February 7, is National Black HIV/AIDS Awareness Day–a day dedicated to raising awareness of the disproportionate impact of HIV on Black Americans and the importance of increasing access to HIV education, testing, treatment, and prevention services. Today's guest is Kelvin Powell, Laboratory Research Assistant at the Fenway Institute. Kelvin Powell is excited to be back at the Fenway Institute, where he is currently working with the Biomedical Research team aiding with Laboratory and Recruitment support on several NIH study grants and COVID-19 Vaccine Trials. Kelvin has experience with educating the community on research by informing the community of latest practices within prevention and biomedical research by breaking down myths about research within the communities of color. Intro and Outro music: https://pixabay.com/music/upbeat-good-vibe-resonance-165302/ Fenway Health Board of Director Application: https://tr.ee/ulQQJ2qJK_ The Pryde Housing Lottery Application: https://www.pennrose.com/apartments/massachusetts/pryde-the/?utm_source=newsletter&utm_medium=email&utm_campaign=application-announcement 

The world's first cancer vaccine has been shown to prevent melanoma reappearing in patients for as long as three years, researchers claim. A long-standing trial into the mRNA-4157/V940 along with immunotherapy drugs produces results which potentially revolutionise cancer treatment.See omnystudio.com/listener for privacy information.

The Bureau of Land Management is increasing its efforts to rein in the number of wild horses roaming the Western U.S.

Egal ob Krankheitssymptome oder Nebenwirkungen von Medikamenten: Placebo-Antworten können Großes bewirken. Die Kehrseite ist der Nocebo-Effekt, der Menschen allein durch negative Erwartungen krank machen kann. Psychologie und Neurologie können diese komplexen Mechanismen neurobiologisch immer besser nachweisen. Wissenschaftsjournalistin Korinna Hennig hat mit Placeboforschern gesprochen und nach Fallberichten gesucht. Im Gespräch mit Host Lucie Kluth erklärt sie, welchen Weg die Schmerzerwartung durch Rückenmark und Gehirn nimmt und welche Rolle Neurotransmitter dabei spielen. Es geht um die erstaunliche Wirkung von grün gefärbter Erdbeermilch, um das Kreuz mit den Beipackzetteln, eine verblüffende Studie mit Parkinson-Patienten - und um zweifelhafte Impfreaktionen in der Pandemie. DIE HINTERGRUNDINFORMATIONEN • Homepage des Sonderforschungsbereichs "Treatment Expectation" | https://treatment-expectation.de/ • Review zu Nocebo-Effekten im Placebo-Arm der Zulassungsstudien von Covid-Impfstoffen | Haas JW, Bender FL, Ballou S et al. Frequency of Adverse Events in the Placebo Arms of COVID-19 Vaccine Trials. A Systematic Review and Mega-analysis. JAMA Network Open. 2022;5(1). https://doi.org/10.1001/jamanetworkopen.2021.43955 • Review zu Nocebo-Effekten im Placebo-Arm von klinischen Studien zu Influenza-Impfstoffen | Bender FL, Rief W, Wilhelm M. Really just a little prick? A meta-analysis on adverse events in placebo control groups of seasonal influenza vaccination RCTs. Vaccine. 2023;41: 294-303. https://doi.org/10.1016/j.vaccine.2022.11.033 • Studie zur Bedeutung des Erwartungseffekts auf das Opioid Remifentanyl | Bingel U, Wanigasekera V et al. The Effect of Treatment Expectation on Drug Efficacy: Imaging the Analgesic Benefit of the Opioid Remifentanil. Science Translational Medicine. 2011;3(70). https://doi.org/10.1126/scitranslmed.3001244 • Studie zu Erwartungshaltung und eigenständiger Steuerung von Schmerztherapien | Strube A, Horing B, Rose M, Büchel C. Agency affects pain interference through prior shift as opposed to likelihood precision modulation in a Bayesian pain model. Neuron. 2023;01(002): 1-16. https://doi.org/10.1016/j.neuron.2023.01.002 • Neurobiologischer Mechanismus bei Placebo-Antworten in der Schmerztherapie | Levine JD, Newton C et al. The Mechanism of Placebo Analgesia. The Lancet. 1978;312(8091): 654-657. https://doi.org/10.1016/S0140-6736(78)92762-9 • Studie zu Placebo-Antworten bei Parkinson-Patienten | Benedetti F, Frisaldi E et al. Teaching neurons to respond to placebos. The Journal of Physiology. 2016;594 (19): 5647-5660. https://doi.org/10.1016/S0140-6736(78)92762-9 • Konditionierung von Organtransplantierten zur Immunsuppression | Schedlowski M, Kirchhof J et al. Learned immunosuppressive placebo responses in renal transplant patients. PNAS. 2018;115(16): 4223-4227 https://doi.org/10.1073/pnas.1720548115 • Qualitative Studie zu Patientenerwartungen bei Open Label Placebos | Haas JW, Ongaro G, Jacobson E et al. Patient's experiences treated with open-label placebo versus double-blind placebo: a mixed methods qualitative study. BMC Psychology. 2022;10(20): https://doi.org/10.1186/s40359-022-00731-w • Querschnittstudie zu Nocebo-Effekten bei Langzeitfolgen einer Corona-Infektion in Frankreich | Matta J, Wiernik E, Robineau O et al. Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Test Results With Persistent Physical Symptoms Among French Adults During the COVID-19 Pandemic. JAMA Internal Medicine. 2022;182(1):19-25. https://doi.org/10.1001/jamainternmed.2021.6454 • Expertenkonsens und klinische Empfehlungen zu Placebo- und Nocebo-Effekten | Evers AWM, Colloca L, Blease C et al. Implications of Placebo and Nocebo Effects for Clinical Practice: Expert Consensus. Psychotherapy and Psychosomatics. 2018;87:204–210. https://doi.org/10.1159/000490354 • Placebo-Effekte in Medizin, Sport, Werbung und Kunst | Bingel U, Schedlowski M, Kessler H. Placebo 2.0. Die Macht der Erwartung. 1. Aufl. Zürich: Rüffer & Rub; 2019. • Nocebo-Effekte in Wissenschaft und Klinik | Heier M. Nocebo: Wer's glaubt wird krank. Gesund trotz Gentests, Beipackzetteln und Röntgenbildern. 3. Aufl. Stuttgart: S. Hirzel Verlag 2013.

Egal ob Krankheitssymptome oder Nebenwirkungen von Medikamenten: Placebo-Antworten können Großes bewirken. Die Kehrseite ist der Nocebo-Effekt, der Menschen allein durch negative Erwartungen krank machen kann. Psychologie und Neurologie können diese komplexen Mechanismen neurobiologisch immer besser nachweisen. Wissenschaftsjournalistin Korinna Hennig hat mit Placeboforschern gesprochen und nach Fallberichten gesucht. Im Gespräch mit Host Lucie Kluth erklärt sie, welchen Weg die Schmerzerwartung durch Rückenmark und Gehirn nimmt und welche Rolle Neurotransmitter dabei spielen. Es geht um die erstaunliche Wirkung von grün gefärbter Erdbeermilch, um das Kreuz mit den Beipackzetteln, eine verblüffende Studie mit Parkinson-Patienten - und um zweifelhafte Impfreaktionen in der Pandemie. DIE HINTERGRUNDINFORMATIONEN • Homepage des Sonderforschungsbereichs "Treatment Expectation" | https://treatment-expectation.de/ • Review zu Nocebo-Effekten im Placebo-Arm der Zulassungsstudien von Covid-Impfstoffen | Haas JW, Bender FL, Ballou S et al. Frequency of Adverse Events in the Placebo Arms of COVID-19 Vaccine Trials. A Systematic Review and Mega-analysis. JAMA Network Open. 2022;5(1). https://doi.org/10.1001/jamanetworkopen.2021.43955 • Review zu Nocebo-Effekten im Placebo-Arm von klinischen Studien zu Influenza-Impfstoffen | Bender FL, Rief W, Wilhelm M. Really just a little prick? A meta-analysis on adverse events in placebo control groups of seasonal influenza vaccination RCTs. Vaccine. 2023;41: 294-303. https://doi.org/10.1016/j.vaccine.2022.11.033 • Studie zur Bedeutung des Erwartungseffekts auf das Opioid Remifentanyl | Bingel U, Wanigasekera V et al. The Effect of Treatment Expectation on Drug Efficacy: Imaging the Analgesic Benefit of the Opioid Remifentanil. Science Translational Medicine. 2011;3(70). https://doi.org/10.1126/scitranslmed.3001244 • Studie zu Erwartungshaltung und eigenständiger Steuerung von Schmerztherapien | Strube A, Horing B, Rose M, Büchel C. Agency affects pain interference through prior shift as opposed to likelihood precision modulation in a Bayesian pain model. Neuron. 2023;01(002): 1-16. https://doi.org/10.1016/j.neuron.2023.01.002 • Neurobiologischer Mechanismus bei Placebo-Antworten in der Schmerztherapie | Levine JD, Newton C et al. The Mechanism of Placebo Analgesia. The Lancet. 1978;312(8091): 654-657. https://doi.org/10.1016/S0140-6736(78)92762-9 • Studie zu Placebo-Antworten bei Parkinson-Patienten | Benedetti F, Frisaldi E et al. Teaching neurons to respond to placebos. The Journal of Physiology. 2016;594 (19): 5647-5660. https://doi.org/10.1016/S0140-6736(78)92762-9 • Konditionierung von Organtransplantierten zur Immunsuppression | Schedlowski M, Kirchhof J et al. Learned immunosuppressive placebo responses in renal transplant patients. PNAS. 2018;115(16): 4223-4227 https://doi.org/10.1073/pnas.1720548115 • Qualitative Studie zu Patientenerwartungen bei Open Label Placebos | Haas JW, Ongaro G, Jacobson E et al. Patient's experiences treated with open-label placebo versus double-blind placebo: a mixed methods qualitative study. BMC Psychology. 2022;10(20): https://doi.org/10.1186/s40359-022-00731-w • Querschnittstudie zu Nocebo-Effekten bei Langzeitfolgen einer Corona-Infektion in Frankreich | Matta J, Wiernik E, Robineau O et al. Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Test Results With Persistent Physical Symptoms Among French Adults During the COVID-19 Pandemic. JAMA Internal Medicine. 2022;182(1):19-25. https://doi.org/10.1001/jamainternmed.2021.6454 • Expertenkonsens und klinische Empfehlungen zu Placebo- und Nocebo-Effekten | Evers AWM, Colloca L, Blease C et al. Implications of Placebo and Nocebo Effects for Clinical Practice: Expert Consensus. Psychotherapy and Psychosomatics. 2018;87:204–210. https://doi.org/10.1159/000490354 • Placebo-Effekte in Medizin, Sport, Werbung und Kunst | Bingel U, Schedlowski M, Kessler H. Placebo 2.0. Die Macht der Erwartung. 1. Aufl. Zürich: Rüffer & Rub; 2019. • Nocebo-Effekte in Wissenschaft und Klinik | Heier M. Nocebo: Wer's glaubt wird krank. Gesund trotz Gentests, Beipackzetteln und Röntgenbildern. 3. Aufl. Stuttgart: S. Hirzel Verlag 2013.

From the long search for an HIV cure to the recent breakthroughs in COVID-19 vaccines, clinical trials have always been a critical part of the response to any public health crisis. People who volunteer for groundbreaking vaccine trials are helping make the future healthier for all of us. But what happens when the communities who need these vaccines the most are left out of their development? How we do address the racial and socioeconomic barriers that create inequities in medical research trials? Let's find out.  Today's guest is Dr. Kathryn Stephenson, Director of the Clinical Trials Unit at Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center.

The DEFRA programme to pilot a vaccine for cattle against Bovine Tuberculosis is about the enter its second stage. This will involve five farms with 600 cattle. The trial combines the BCG vaccine and the DIVA test, which shows clearly which cattle have been vaccinated and which have been challenged by the disease, and it's hoped both together could work to identify where the disease is and also protect cattle at risk. There's been a re-organisation of government departments. Grant Shapps is the new Energy Security and Net Zero Secretary; Michelle Donelan becomes the Science, Innovation and Technology Secretary. Both of those roles will have to liaise closely with DEFRA - on the future of land use for energy, and innovations including gene editing. All week we're taking a look at the future of our peatlands. In many parts of the country lowland peat is drained and used to grow vegetables and other crops but this degrades the peat and emits carbon. Farmers in Germany are developing something called ‘paludiculture', using re-wetted peat lands to grow water tolerant vegetation, which also has a market. A company called Wetland Products is growing bulrushes in water-covered peat and turning it into housing insulation, takeaway food packaging, and compost for commercial growers. Bulrushes and reeds also clean up the excess nutrients in the water where they grow. Also in the Fens, a group of farmers and scientists are working together to see if they can change the way farming food is done on peatlands. A collaboration called Fenland Soil has been set to try out new wetter farming techniques. Presenter = Anna Hill Producer = Rebecca Rooney

Show Notes: First human patients receive transfusions of lab-grown blood cells | New Atlas (01:01)  For the first time ever, human patients have received transfusions of blood cells that were grown from stem cells in a lab  Revolutionize blood transfusions Blood donations are life saving, but the demand outweighs the supply But only 13.6 million units of whole blood and red blood cells are collected in the U.S. in a year. According to the Red Cross, only about 3% of age-eligible people donate blood yearly. Nearly 16 million blood components are transfused each year in the U.S. Approximately 29,000 units of red blood cells are needed every day in the U. S.  An attractive alternative would be large-scale production of red blood cells in labs, which can be tuned to have whichever blood type is needed.  The new clinical trial, named RESTORE, is designed to test the safety of transfusions of these manufactured blood cells, as well as how long they last in the body. Lab-grown blood  is all made “fresh,” so it should all reliably last up to 120 days. For people with conditions that require regular blood transfusions, such as sickle cell, the longer lifespan of the cells should help give them longer gaps between transfusions.  The RESTORE trial will involve at least 10 participants receiving “mini” transfusions of blood, containing just 5 to 10 ml (one to two teaspoons) of red blood cells. So far, two participants have received transfusions of lab-grown blood cells as part of the trial, with the scientists reporting that they have shown no untoward side effects. While this is a major milestone towards that goal, there's still much more work to do before blood transfusions are regularly lab-grown This clear window coating could cool buildings without using energy | Electrek (06:41) Scientists have used advanced computing tech and AI to design a clear window coating that could lower the temperature inside buildings. Saving a whole lot of cooling energy. Cooling accounts for about 15% of global energy consumption, and it's only going to get hotter, especially in more tropical climates. The sun's ultraviolet and near-infrared light are the parts of the solar spectrum that pass through window glass to heat an enclosed room. Why a car gets hot sitting in the sun. If you block that light energy the amount of cooling needed would be reduced According to their new paper, researchers from University of Notre Dame in Indiana and Kyung Hee University in Seoul, successfully designed a clear window coating, or “transparent radiative cooler” (TRC). According to the report,  “[The team] optimized the type, order, and combination of layers using an iterative approach guided by machine learning and quantum computing, which stores data using subatomic particles” Using this quantum method allowed the team to carry out the optimization process faster. Which eventually, “produced a coating design that, when fabricated, beat the performance of conventionally designed TRCs in addition to one of the best commercial heat-reduction glasses on the market.” Through heat simulations of the TRC as a potential window material for a standard office with two windows they were able to figure out roughly the heat savings. 31.1% of the cooling energy consumption when conventional windows are used. The average annual energy saving over the surveyed U.S. cities is 50 MJ/m2 In cities with hot, dry weather the TRC can potentially save around 86.3 MJ/m2 per year. There's no indication of commercial scaling in the study, but the researchers write that the film “can be potentially scaled up for practical applications because their fabrication can be achieved using state-of-the-art deposition techniques.” Experimental breast cancer vaccine passes first human trials   | New Atlas (12:19) I don't like using the term vaccine for these types of treatments. It is more of cell/protein therapy so I'll put that out there before I get into this. Up to 30% of breast cancers involve the overproduction of a protein called human epidermal growth factor receptor 2 (HER2).  HER2-positive cancers are often more aggressive than other types of breast cancer These treatments deliver DNA blueprints for the production of certain proteins into the nucleus of a cell. The protein is then produced by the cell, triggering an immune response.  This treatment in question prompts cells to produce a specific fragment of the HER2 protein. Note another reason I don't call it a vaccine:  These are known as “therapeutic vaccines”, given to patients after they are diagnosed with a cancer in the hopes they help the immune system better seek and destroy certain tumors. The trial was not geared to evaluate how effective the experimental treatment is at treating breast cancer.  But still in the trial there were promising signs of efficacy, with 80% of the treated trial participants surviving the full 10-year follow-up Only around 50% of patients with advanced HER2 breast cancer would generally be expected to survive more than five year Looking into the survival rate: 95.8% of females survive breast cancer for at least one year, this falls to 85.0% surviving for five years or more, and continues to fall to roughly 75% for 10 years,  as shown by age-standardized net survival for patients diagnosed with breast cancer during 2013-2017 in England. A Phase 2 trial is currently underway, testing the treatment's efficacy in a larger cohort of HER2-positive patients. Scientists are working on an official 'alien contact protocol' for when ET phones Earth | Live Science (19:01) For the first time in 35 years, a team of policy experts and scientists have united to establish a set of alien-contact protocols for the entire world to follow in the event of a sudden encounter with E.T.  What better use of “policy experts” … unless they know something Currently, the only alien contact protocol that humans have was established by the Search for Extraterrestrial Intelligence Institute (SETI) community in 1989. vague when it comes to the international response to extraterrestrial communication mainly focuses on the importance of sharing discoveries with the public and broader scientific community. The new SETI Detection Hub will scan signals for potential messages sent from alien lifeforms and will develop a framework for attaching meaning to those signals. End it with John Elliot, a computer scientist at the University of St. Andrews in Scotland, and coordinator of the SETI Detection Hub, talking on the preparedness effort: “Will we ever get a message from E.T.? We don't know. We also don't know when this is going to happen … But we do know that we cannot afford to be ill-prepared — scientifically, socially, and politically rudderless — for an event that could turn into reality as early as tomorrow." Open-source fish robot starts collecting microplastics from UK lakes | The Next Web (24:20) Microplastics in the water is a problem: A new study from Stanford University found that blue whales, the biggest creatures on Earth, ingest about 10 million pieces of microplastics per day. What could be the solution? Maybe a plastic eating robot fish? A robot fish that collects microplastics from waterways has been turned from an idea into a working prototype.  The design was brought to life after it won the University of Surrey's public competition, the Natural Robotics Contest. Competition was to submit an idea for a bio-inspired robot that could help the world. The robotics panelists and researchers, led by Dr. Robert Siddall, turned the design into a 3D-printed prototype about the size of a salmon. consists of a flooded head unit and a watertight tail unit. Set of gills on its sides and a fine mesh in between them that can sieve about two-millimeter particles Filters the water and keeps the microplastics inside its container as it swims. The robot fist has already been tested in the lab and local lakes  Going Forward, according to Siddall, the team is envisioning a range of improvements for the robot: Making It faster and smarter Operate autonomously, rather than being remote controlled.

2249: Enrolling Minors in COVID-19 Vaccine Trials; The Democratic Party Are Crushing Your Prosperity

Brianne Dressen wanted to do the right thing when she signed up for AstraZeneca's COVID-19 vaccine trials.  She had faith the government would get things right.  Within 24 hours, her health deteriorated to the point that she could no longer work at her beloved pre-school.  In the time since, she has racked up millions — yes millions — of healthcare bills.  And where is AstraZeneca?  Where is the FDA?  Where is the NIH?  Brianne answers all those questions with Michele.See omnystudio.com/listener for privacy information.

There are people who don't want you to hear Brook Jackson's story.  Why?  Because her allegations about COVID-19 vaccine trials are damning.  Brook is a whistle-blower, and she joins Michele to talk about how Pfizer and the FDA ignored her alarm bells about the vaccine trials.  This story isn't over.See omnystudio.com/listener for privacy information.

Mathew and Dan discussion whether or not COVID-19 vaccine trial results are valid without confirmation that the vaccines do not confound the PCR test used to diagnose COVID-19.Subscribe to Rounding the Earth on Substack: https://roundingtheearth.substack.com/Support us by checking out our sponsor page: https://roundingtheearth.substack.com/p/rounding-the-earth-sponsors-and-partnersFollow us on all our platforms:Rumble: https://rumble.com/c/c-1718605Odysee: https://odysee.com/@RoundingtheEarth:8YouTube: https://www.youtube.com/channel/UCp2V_2S02t-F69FZdFRlMXwRokfin: https://rokfin.com/RoundingtheEarthBitChute: https://www.bitchute.com/channel/roundingtheearth/Brighteon: https://www.brighteon.com/channels/roundingtheearthTwitter: https://mobile.twitter.com/RoundEarthClub/Visit the Campfire Wiki: https://www.campfire.wiki/

CDC Admits to Lying about Vaccine Trials! You Have to Hear This!

Chris Masterjohn joins Mathew Crawford for a discussion of strange differences in the reporting of symptoms in COVID-19 quasi-vaccine clinical trials.Find Chris at https://chrismasterjohnphd.comSubscribe to Rounding the Earth on Substack: https://roundingtheearth.substack.com/Support us by checking out our sponsor page: https://roundingtheearth.substack.com/p/rounding-the-earth-sponsors-and-partnersFollow us on all our platforms: Rumble: https://rumble.com/c/c-1718605Odysee: https://odysee.com/@RoundingtheEarth:8YouTube: https://www.youtube.com/channel/UCp2V_2S02t-F69FZdFRlMXwRokfin: https://rokfin.com/RoundingtheEarthBitChute: https://www.bitchute.com/channel/roundingtheearth/Brighteon: https://www.brighteon.com/channels/roundingtheearthTwitter: https://mobile.twitter.com/eduengineer/Visit the Campfire Wiki: https://www.campfire.wiki/

The Vaccination Against Canine Cancer Study (VACCS) is testing out a vaccine that will hopefully prevent dogs from getting eight of the most common cancers. As of June 1st the study finished enrolling 800 healthy dogs, each of whom will be followed for five years after getting the initial vaccination series. Listen in to hear Dr. Jenna Burton, one of the oncologists working on the study, explain how the vaccine was designed, which dogs can participate, and what they are hoping to see and learn. Even if the vaccine doesn't perform as well as hoped, this study will provide a huge amount of valuable information on cancer development in dogs that can help all of our future canine companions. Links Mentioned in Today's Show: VACCS Trial – Colorado State University VACCS Trial – University of Wisconsin-Madison VACCS Trial – University of California-Davis Open Philanthropy Related Links: Early Dog Cancer Prevention and Vaccine Trials podcast episode Could a Vaccine Prevent Dog Cancer? podcast episode About Today's Guest, Dr. Jenna Burton: Dr. Jenna Burton completed veterinary school at The Ohio State University then joined the team at the Flint Animal Cancer Center at Colorado State University (CSU) as an intern, medical oncology resident, and finally as a faculty member. In 2014, Dr. Burton joined the faculty of the University of California, Davis where she served as the director of the Veterinary Center for Clinical Trials. She returned to CSU in 2020 and is currently an Associate Professor in the Flint Animal Cancer Center. Her research is focused on the conduct of clinical trials to improve the health and treatment of pets with cancer, with an emphasis on comparative oncology trials. LinkedIn Other Links: To join the private Facebook group for readers of Dr. Dressler's book “The Dog Cancer Survival Guide,” go to https://www.facebook.com/groups/dogcancersupport/  Dog Cancer Answers is a Maui Media production in association with Dog Podcast Network This episode is sponsored by the best-selling animal health book The Dog Cancer Survival Guide: Full Spectrum Treatments to Optimize Your Dog's Life Quality and Longevity by Dr. Demian Dressler and Dr. Susan Ettinger. Available everywhere fine books are sold. Have a guest you think would be great for our show? Contact our producers at DogCancerAnswers.com Have an inspiring True Tail about your own dog's cancer journey you think would help other dog lovers? Share your true tail with our producers. If you would like to ask a dog cancer related question for one of our expert veterinarians to answer on a future Q&A episode, call our Listener Line at 808-868-3200 www.dogcanceransers.com. Dog Cancer News is a free weekly newsletter that contains useful information designed to help your dog with cancer. To sign up, please visit: www.dogcancernews.com Learn more about your ad choices. Visit megaphone.fm/adchoices

Vaccines have been an important part of the world over the past two years. Today, we'll hear how many trials UVM runs, what medications and clinical approaches are being tested, who originates them and what benefit they are to the public. Then Elliott Greenblott of the AARP Fraud Network returns to warn us about the scams that are currently making the rounds. After that, we get ready for the opening of the Vermont Mountaineers' 19th season in Montpelier. And we finish the morning discussing the most-recent Legislative session with Governor Phil Scott. 

This week we spotlight the Human Rights Council's special session on atrocities happening in Ukraine, post Russia's invasion. We'll also be heading to Afghanistan for the latest alarming UN assessments on food insecurity there, and to the Occupied West Bank - after the killing of Al Jazeera journalist Shireen Abu Akleh - and to DPR Korea, where health agency WHO, is committed to do help stop the spread of COVID-19. We also have some good news about successful malaria vaccine trials in Africa, which could save tens of thousands of children's lives.

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering updates from FDA's vaccine advisory committee meeting regarding a revised version of the COVID vaccine for fall, the FDA suspending use of a monoclonal antibody drug by GlaxoSmithKline known as sotrovimab to treat high-risk COVID-19 patients in the U.S. because it's unlikely to be effective against BA.2, and a clinical trial published in NEJM confirms that the anti-parasitic drug, ivermectin, showed no sign of alleviating COVID.

Email: Uncommonpodcast@outlook.comFacebook: @UncommonPODTwitter: @UncommonPC Instagram:  @dustin.duff     @Bpop80    Gettr: @DuffdbGab: @Duffdb   Clips:Fuck Your Feelings Song:Battleplan Faucihttps://battleplan.news/watch?id=6226eae9ba680459ec8f3e62Moderna CEO on genetic sequencing of vax and covidhttps://noagendaassets.com/enc/1645997560.37_modernapresidentbancelgetscalledoutbymoneyhoneyforhavingthesamegeneticsequencepatented3yearsbeforethepandemic.mp3Biden: Government Spending Doesn't Lead to Inflationhttps://noagendaassets.com/enc/1647202455.293_bidenissickofpeoplethinkinginflationisbecuaseofgovernmentsspendingmoremoney.mp3Takes Naps “Woman of the Year” https://www.instagram.com/reel/CbLBliPgev1/?utm_medium=copy_link Biden Aid to Ukrainehttps://noagendaassets.com/enc/1647202469.123_moreaidtoukrainenpr.mp3Scott Ritter (Fmr USMC) Explains US finding of Nazis in 2014-2022https://noagendaassets.com/enc/1647202499.205_scottritter-frmrusmc-explainsusfindingofnazisin2014-2022.mp3Dr Ryan Cole Pfizer Doc Releasehttps://twitter.com/drsimonegold/status/1503840470799159306?s=20&t=_5TUk9wCVyO8cuS-k44jPASchwab Gene Editinghttps://noagendaassets.com/enc/1647202484.817_klauschwab4thindustrialrevolutionchangesyouwithgeneediting-charlierose.mp3Pfizer 4th Shothttps://noagendaassets.com/enc/1647548286.53_abcgma-anchorevapilgrim-phizer4thshotb.a.21min.mp3Biden Funding Ukrainehttps://noagendaassets.com/enc/1647548337.219_abcgma2anchorceciliavega-listofweaponsgiventoukraine1min13sec.mp3Edward Dowd [Frmr Blackrock] DEMOCIDE - CDC data shows massive excess mortality in millennials AFTER JABShttps://noagendaassets.com/enc/1647202499.205_edwarddowdfrmrblackrockdemocide-cdcdatashowsmassiveexcessmortalityinmillennialsafterjabs.mp3 Ukraine universal basic income only with digital COVID vax passhttps://twitter.com/IrishAmerican27/status/1504601539716993035?s=20&t=qnUEnLF2prVHNOS5SJSeIA

Instead of trying therapies and hoping for the best, the RECOVERY trial investigators designed randomized trials to test which therapeutics were truly effective for COVID-19. Dr Harrington interviews lead investigator Martin Landray, MB ChB, PhD. To read a transcript or to comment: https://www.medscape.com/author/bob-harrington The Bob Harrington Show is intended for healthcare professionals. RECOVERY Trial Website and Some Publications Randomized Evaluation of COVID-19 Therapy https://www.recoverytrial.net/ Dexamethasone in Hospitalized Patients with Covid-19 https://www.nejm.org/doi/full/10.1056/nejmoa2021436 Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial https://doi.org/10.1016/S0140-6736(20)32013-4 Remdesivir for the Treatment of Covid-19 — Final Report https://www.nejm.org/doi/full/10.1056/nejmoa2007764 Dexamethasone in Hospitalized Patients with Covid-19 https://www.nejm.org/doi/full/10.1056/nejmoa2021436 Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19 https://www.nejm.org/doi/full/10.1056/NEJMoa2022926 Clinical Trials and Informed Consent The good Clinical Trials Collaborative https://www.goodtrials.org/ Why do we need some large, simple randomized trials? https://doi.org/10.1002/sim.4780030421 Assessment of Length and Readability of Informed Consent Documents for COVID-19 Vaccine Trials http://jamanetwork.com/article.aspx?doi=10.1001/jamanetworkopen.2021.10843 You may also like: Medscape Editor-in-Chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine https://www.medscape.com/features/public/machine Hear John Mandrola, MD's summary and perspective on the top cardiology news each week, on This Week in Cardiology https://www.medscape.com/twic Questions or feedback? Please contact: news@medscape.net

Christofer, Marek Doyle and Dr. Purvi Parikh speak about the COVID-19 vaccines in this episode of Do Explain. They discuss their effectiveness/efficacy, CDC's change in reporting of breakthrough infections, methodological limitations of certain studies, vaccine safety, comparing COVID-19 with the flu, natural immunity, self-reporting, and other related topics.Marek Doyle is a functional nutritional therapist based in London, England. He has spent the last 15 years reconciling the data from 2,000 patient outcomes and 9,000 test results to build a model of personalized nutrition, and has been featured by a range of media, such as Sky Sports, the Daily Mail, Mens Health and Marie Claire.Instagram: https://www.instagram.com/marekdoylenutritionWebsite: https://www.marekdoyle.com/Purvi Parikh, MD, is an immunologist and allergy specialist at NYU who has been involved in the Pfizer and AstraZeneca COVID-19 Vaccine Trials. Dr. Parikh practices in New York City at Allergy and Asthma Associates of Murray Hill and New York University School of Medicine. She also sits on the Board of Directors for the advocacy council of the American College of Allergy, Asthma & Immunology, and have appeared as a medical expert on CNN, CNBC and CBS News, among others.  Instagram: https://www.instagram.com/panipurvinyc Twitter: https://twitter.com/purviparikhmd[NOTE: References and additional comments for this discussion went over the allowed character limit and can instead be found in the following blog post on the Do Explain website: https://www.doexplain.org/episodes/33-in-a-sea-of-studies-covid-19-vaccines-with-marek-doyle-and-dr-purvi-parikh]Support the podcast at:patreon.com/doexplain (monthly)ko-fi.com/doexplain (one-time)Find Christofer on Twitter:https://twitter.com/ReachChristofer

Hosts Loren DeJonge Schulman and Rachel Klein-Kircher talk to Drs. Gary Gibbons and Eliseo Pérez-Stable from the NIH about their groundbreaking efforts to tackle COVID-19 health disparities. The two leaders discuss the importance of diverse vaccine trials, what the pandemic has taught them about promoting health equity and the latest vaccine acceptance rates in underserved communities. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Catch up on the most important news today in 2 minutes or less. Get even more news you can use with the Tech in Two newsletter. Sign up here: https://www.wired.com/tt

In this episode, we speak with Stanley Wang, a participant in phase 2/3 of the Pfizer COVID-19 Vaccine Trial. We discuss the timeline for vaccine trials, as well as why he felt compelled to participate.

Welcome back healthy people! On this episode of On Call with Dr. Randy I'll be discussing vaccine trials. Do you know the stages of how a vaccine is approved? Well you'll find out on this episode! I'll also chat it up with Ashley Nealy. Ashley Nealy is an assistant director for the federal government and the Founder and Chief Creative Officer of Mindly Mave, LLC, a web design company. Last year she participated in the Pfizer Covid-19 Vaccine trial. Want hear how it went with her? Well take a listen!   [00:01 – 06:14] Healthy People Information Phases of a Vaccine trial Exploratory stage Pre-clinical stage Safety and Right dosage Effectivity of the vaccine Regulatory approval and Licensure Will it stay safe down the road?   [07:15 – 13:57] Interview with Ashley Nealy The first time Ashley heard about COVID-19 First brush with the pandemic How COVID affected Ashley's life on a daily basis   [13:58 – 28:35] The Process of Ashley's vaccine trials Why she volunteered for the Covid-19 Vaccine trials Reassurance of safety when joining the vaccine trials Ashely talks about the process of her Vaccine trials Tracking and monitoring symptoms and side effects due to the vaccine   [28:36 – 43:00] Spreading Awareness about the Importance of Vaccination Convincing people to get themselves vaccinated Spreading awareness about the importance of getting vaccinated Ashley's role in spreading awareness about the importance of a vaccine Why you shouldn't be worried about the vaccine Why you should participate in clinical trials Sign up and Volunteer   [43:01 – 48:23] Randy's Random Questions with Ashley Nealy What's the best part about being a cheerleader? Which interview has been the most fun interview you've done about the Covid vaccine? Why do we need more Black women in tech? What is the most fun thing you've done in the tech industry? What are the best food spots in Atlanta?   [48:24 – 55:56] Closing Segment Recap of key information discussed in the episode The Emergency Use Authorization Final Words from me   Tweetable Quotes: “We will never reach immunity unless people get vaccinated.” - Ashley Nealy “Always ask your doctor and always make the best decision for you and your family.” - Ashley Nealy “I can't convince anyone to take the vaccine, but I can just tell them about my experience and the data they need to make a decision.” - Ashley Nealy “People should participate in the vaccine trials because you are contributing to science.” - Ashley Nealy     Resources and Links Mentioned: Importance of Mouse Genome Human Challenge Trials Vaccine Development, Testing, and Regulation 5 Stages of COVID-19 Vaccine Development Keep up with Ashely on LinkedIn, Instagram, and Twitter, and Tiktok.   To know more, you can connect with me on Instagram, Facebook, and Twitter. Also, visit my website https://hinesentertainment.com/ or email me at hinesentertainmentgrp@gmail.com    LEAVE A REVIEW AND RATING + help someone who wants to learn more about useful health information by sharing this episode or click here to listen to more episodes.

Johnson & Johnson released the efficacy results of their one-shot Covid-19 vaccine candidate as coronavirus variants are increasingly being found in the U.S. The company announced their vaccine was shown to be 66% effective in preventing moderate and severe disease in a global Phase 3 trial and 85% effective against severe disease. It also was shown to be 72% effective against moderate and severe diseases in the U.S. While the trial apparently shows a lower efficacy rate than the other two vaccines on the market from Pfizer and Moderna, experts say the Johnson & Johnson vaccine would help fight the pandemic. Dr. Leana Wen is the former Baltimore Health Commissioner, an emergency room physician and a CNN Medical Analyst. She tells Anderson Cooper these results are promising. Plus, Pres. Joe Biden plans to intensify public lobbying for his Covid-19 relief bill and says it “has to pass.” Independent Senator Bernie Sanders has said the timeline for this bill to pass is “as soon as we possibly can.” He joins AC360 to give an update on where the $1.9 trillion bill stands on Capitol Hill and whether or not the Democrats have the votes to pass without any Republican support. Airdate: January 29, 2021 Guests: Dr. Leana Wen Sen. Bernie Sanders To learn more about how CNN protects listener privacy, visit cnn.com/privacy

Dr. Ramchandani discusses the history of human experimentation in the United States and the difference between these experiments and the current COVID-19 Vaccine trials.  

In today's episode episode we discuss a number of topics. COVID-19, Relief Checks, "Trumpism", and Vaccinations. Our culture has an extended background when it comes to vaccines and the lack of information that has been provided to us. Our inclusion as test subjects but exclusion as equal under the flag of America.

Vaccine Trials, Rollout Reaction; Black Water Dive Guide; Reality Check: Uncertainty Surrounding Rail Bids; Waikiki Film

In the inaugural episode of “The COVID Pod with Ashish Jha,” The Brown Daily Herald's editor-in-chief Colleen Cronin joins Brown's Dean of the School of Public Health Ashish Jha, MD, MPH on Zoom to discuss the national news surrounding ongoing vaccine trials, President Donald Trump's COVID-19 diagnosis and treatment and the risk of group gatherings. Jha provides expert insight into the state of affairs in Rhode Island, at Brown and across the country. Recorded on Friday, October 16, 2020. 

Chris discusses Johnson & Johnson pausing coronavirus vaccine trials due to “unexplained illness” in volunteer with Dr. Ashish Jha and David Axelrod. Then, Chris goes one on one with Senator Cory Booker on day one of Judge Amy Coney Barrett Supreme Court confirmation hearings. Chris wraps up the show with California Secretary of State Alex Padilla on the investigations into fake ballot drop boxes in California. To learn more about how CNN protects listener privacy, visit cnn.com/privacy

Chris discusses Johnson & Johnson pausing coronavirus vaccine trials due to “unexplained illness” in volunteer with Dr. Ashish Jha and David Axelrod. Then, Chris goes one on one with Senator Cory Booker on day one of Judge Amy Coney Barrett Supreme Court confirmation hearings. Chris wraps up the show with California Secretary of State Alex Padilla on the investigations into fake ballot drop boxes in California. To learn more about how CNN protects listener privacy, visit cnn.com/privacy

Chris discusses the latest coronavirus developments with Infectious Disease Specialist, Dr. William Schaffner, the uncertain future of professional sports seasons with CNN contributor, Bob Costas, and honors the life and legacy of Representative John Lewis. To learn more about how CNN protects listener privacy, visit cnn.com/privacy

Chris discusses the latest coronavirus developments with Infectious Disease Specialist, Dr. William Schaffner, the uncertain future of professional sports seasons with CNN contributor, Bob Costas, and honors the life and legacy of Representative John Lewis. To learn more about how CNN protects listener privacy, visit cnn.com/privacy